Soulpower Acquisition Corp. Class A SOUL 深 滬

Soulpower Announces Merger to Form SOUL WORLD BANK

Soulpower Acquisition Corp. Class A ( ($SOUL) ) has issued an announcement. On ...

11-25 01:08

Soulpower To Take 'SOUL World Bank' Public In $8B Deal Aimed At Reinventing Global Banking

Soulpower Acquisition Corporation (NYSE:SOUL) ("Soulpower") announced today that it has entered into a definitive business combination agreement (the "BCA") for a proposed business combination (the "Business

11-24 19:06

首尔观光财团在上海举办生活方式与文化体验推广活动

10-23 10:13

太平洋证券-医药行业日报：诺和诺德口服司美格鲁肽在欧盟获批新适应症-250917

（来源：研报虎） 市场表现： 　　2025年9月17日，医药板块涨跌幅-0.23%，跑输沪深300指数0.84pct，涨跌幅居申万31个子行业第24名。各医药...

09-18 19:02

What's Going On With Novo Nordisk Shares Monday?

Novo Nordisk shares are trading higher Monday after the company announced European Union approval for oral semaglutide to reduce cardiovascular death, heart attack and stroke.

09-16 03:26

Novo Nordisk's Rybelsus Now First Oral GLP-1 RA In Europe With Proven Heart Health Impact

EMA approved Rybelsus' label update after the SOUL trial showed it cuts heart attack, stroke, and death by 14% in high-risk type 2 diabetes patients.

09-16 01:23

【中泰传媒&轻工|深度】泡泡玛特：三周期共振，生态化延展

（来源：传媒产业大视点） 公司盈利及估值 备注：股价截止自2025年09月04日收盘价，每股指标按照最新股本数全面摊薄...

09-06 07:41

北美匿名社交，为何总活不过三年？

一块蛋糕分不完。 “北美还没有出现一个匿名社交的巨头。“最近，某位社交类app的联合创始人如此向霞光社说道。匿名社交在北美的历史并不短。2012年，陌生人匿名社...

08-26 10:00

Novo Nordisk To Present New Cardiovascular Data On Wegovy And Ozempic At ESC Congress 2025, Including Insights On Role Of Inflammation In ASCVD

Data to highlight the impact of Wegovy® (semaglutide 2.4 mg) on atrial fibrillation – a common heart rhythm condition – in people living with obesity (SELECT study)Additional Rybelsus® and Ozempic® data

08-20 21:35

Soulpower Appoints New President Amid Strategic Moves

An announcement from Soulpower Acquisition Corp. Class A ( ($SOUL) ) is now ava...

07-12 05:50